Rep. Pelosi Issues Statement on President Trump’s Medicare Drug Announcement
Targeted News Service
WASHINGTON, Oct. 25 -- House Minority Leader Nancy Pelosi, D-California, issued the following statement on President Trump's announcement on Medicare Part B drug prices, while continuing not to demand lower prices for seniors with Medicare Part D, which is 3.5 times larger:
"After nearly two years of spitefully acting to raise American's health costs, slash Medicare and Medicaid, and destroy protections for people with pre-existing conditions, it is hard to take President Trump seriously on prescription drug prices with this proposal just 12 days from the election.
"Unless there is a Democratic Congress to back the real, tough legislative authority needed to lower prescription drug prices, the President's newfound interest will disappear just like the rest of his broken promises - same as his phantom infrastructure bill, same as his promise not to cut Medicare and Medicaid, same as his promise to protect people with pre-existing conditions. Even now, President Trump is still refusing to negotiate the Medicare Part D drug prices which are crushing our seniors.
"Instead of lowering drug prices, Republicans used their two years with complete control of Washington to try to destroy protections for pre-existing conditions and hand massive tax windfalls to Big Pharma with their GOP tax scam for the rich. Democrats have made real action to lower prescription drug prices a top legislative priority of our For The People agenda, and that is what a Democratic Majority will deliver."
Universal parks revenue down from Japan natural disasters
FEMA Rebuilding Advice Available at Wells Hardware in Cordele
Advisor News
- Equitable launches 403(b) pooled employer plan to support nonprofits
- Financial FOMO is quietly straining relationships
- GDP growth to rebound in 2027-2029; markets to see more volatility in 2026
- Health-related costs are the greatest threat to retirement security
- Social Security literacy is crucial for advisors
More Advisor NewsAnnuity News
- Best’s Special Report: Analysis Shows Drastic Shift in Life Insurance Reserves Toward Annuity Products, and a Slide in Credit Quality
- MetLife to Announce First Quarter 2026 Results
- CT commissioner: 70% of policyholders covered in PHL liquidation plan
- ‘I get confused:’ Regulators ponder increasing illustration complexities
- Three ways the Corebridge/Equitable merger could shake up the annuity market
More Annuity NewsHealth/Employee Benefits News
- Clash of Titans: Hawai'i's Healthcare Leaders Disagree on Best Path Forward
- Insurance resolution sparks backlash
- Municipalities contend with surprise bills as health costs rise
- Health care in America should be redesigned
Op-ed: We should redesign health care in America. Here's a plan that would help Nebraskans (copy)
- Humana and Thor hit the Casualty List, can revive and thrive
Humana and Thor Hit the Casualty List
More Health/Employee Benefits NewsLife Insurance News
- An Application for the Trademark “PREMIER ACCESS” Has Been Filed by The Guardian Life Insurance Company of America: The Guardian Life Insurance Company of America
- AM Best Assigns Credit Ratings to North American Fire & General Insurance Company Limited and North American Life Insurance Company Limited
- Supporting the ‘better late than never’ market with life insurance
- Best’s Special Report: Analysis Shows Drastic Shift in Life Insurance Reserves Toward Annuity Products, and a Slide in Credit Quality
- The child-free client: how advisors can support this growing demographic
More Life Insurance News